We are delighted to announce that following our first ever virtual inspection by the AABB, our results were ‘excellent.’
Since 1957, AABB has accredited facilities throughout the world and AABB accreditation is an international mark of excellence that demonstrates your facility’s commitment to quality and safety to patients, donors, regulatory agencies, insurance companies and more.
Despite the current challenges posed by the global pandemic, Biovault Family continues with its very high standards of quality and safety in all our activities.
Biovault’s CEO Kate Sneddon said: “This gives us great confidence that despite our adapted working practices and disparate team, with many of us continuing to work from home, we still offer a great service with a high commitment to quality.”
We actively seek out and work towards accreditations that insist on the highest industry standards worldwide, ensuring that Biovault Family leads the way in ethical cord blood banking. Find out more about our accreditations here.
BSc (Hons) Microbiology
Biovault Family CEO, Kate Sneddon, joined Biovault in July 2009 and became Chief Executive Officer in 2016. As health industry professional her experience includes working as a microbiologist and leader at GSK for over 10 years. Her expertise in cord blood banking has been recognised in her awards, features in Parliamentary Review and Parents Guide to Cord Blood, as well as contributions to research with UCL and others.